Call for Abstract
3rd International Conference on Central Nervous System Disorders & Therapeutics, will be organized around the theme “Accelerate the Diagnosis, Prevention & Management of CNS Disorders”
CNS 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in CNS 2017
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Central Nervous System may be defined as the system which is made up of the brain and spinal cord. The CNS is vulnerable to various disorders. CNS can be damaged by the following: Trauma, Infections, Degeneration, Structural defects, Tumours, Blood flow disruption, Autoimmune disorders etc.
Approximately 22 million patients suffer from various forms of dementia, two-thirds of which are related to Alzheimer’s. The WHO estimates the number of people suffering from multiple sclerosis worldwide at 2.5 million. As for schizophrenia, 1percent of the world’s population may be at risk.
- Track 1-1Addiction
- Track 1-2Holoprosencephaly
- Track 1-3Cerebellum : Aging and cognitive syndrome
- Track 1-4Pathophysiology of CNS disorders
- Track 1-5White matter diseases
- Track 1-6Hydrocephalus
- Track 1-7Spinal meningitis
- Track 1-8Neuromyelitis optica
- Track 1-9Neuronal and axonal damages
- Track 1-10Encephalitis
- Track 1-11Autoimmune disorders
- Track 1-12Arnold–Chiari malformation
- Track 1-13Epilepsy/Seizures
- Track 1-14Functional and structural disorders
- Track 1-15Fibromyalgia syndrome
- Track 1-16Cerebral edema
- Track 1-17Brain Infections and abscess
- Track 1-18Brain dysfunction
- Track 1-19Prevention, Treatment and Therapeutic options
Cerebral dysfunction may be focal or global. Focal dysfunction is caused by structural abnormalities and global dysfunction is caused by toxic-metabolic disorders and diffuses inflammation, vasculopathy, major trauma, or disseminated cancer; these diseases affect multiple dimensions of cerebral function.
Every year, an estimated 30,000 people in the United States experience a ruptured cerebral aneurysm and as many as 6percent may have an un-ruptured aneurysm.
- Track 2-1Cerebral hemorrhage
- Track 2-2Epidemiology of cerebrovascular diseases
- Track 2-3Risk factors for cerebrovascular diseases
- Track 2-4Vascular malformation
- Track 2-5Stroke and Transient ischaemic attack
- Track 2-6Cerebral aneurysm
- Track 2-7Cerebral embolism
- Track 2-8Hypertension
- Track 2-9Cerebral Palsy
- Track 2-10Cerebral Ischemia
- Track 2-11Technological advances in vascular surgery
Neuronal Disorders may be defined as the disorders of the Brain, Spine and nerves that connect them. For example: Alzheimer's disease (AD) Epilepsy, Multiple sclerosis etc.
According to World Health Organization report- various types of neurodegenerative disorders affect millions of people around the world, including 25 million that suffer from Parkinson disease and 327 million who experience headaches and migraines.
- Track 3-1Brain Disorders
- Track 3-2Spinal Disorders
- Track 3-3Depression
- Track 3-4Attention Deficit Hyperactivity Disorder
- Track 3-5Amyotrophic Lateral Sclerosis Disease
- Track 3-6Multiple sclerosis and CNS demyelinating disorders
- Track 3-7Migraines and Headaches
- Track 3-8Senility
- Track 3-9Schizophrenia
- Track 3-10Autism and neurodevelopmental disorders
- Track 3-11Parkinsonism and Movement Disorders
- Track 3-12Dementia (AD)
- Track 3-13Prion disease
- Track 3-14Werdnig-Hoffmann Disease
- Track 3-15Neuroinflammation diseases
- Track 3-16Diagnostics of neurological disorders: Neuroimaging, Biomarkers and laboratory studies
Neurosurgery may be defined as the surgical specialty that is concerned with the diagnosis and surgical treatment of the CNS and Peripheral Nervous System. It is also known as Neurological Surgery. It is performed by a physician called neurosurgeon. Based on nature of disorders or diseases, neurosurgeons provide operative and non-operative care. It helps to treat patients with brain tumour, head and spinal cord injury. Types of Neurosurgery include: I).Endovascular Neurosurgery, II).Oncological Neurosurgery III).Stereotactic Neurosurgery so on.
- Track 4-1Brain and Spinal surgery
- Track 4-2Post-surgical neuralgias
- Track 4-3Tumour and metastatis
- Track 4-4Current Neurosurgery methods
- Track 4-5Vascular malfunctions and surgery
- Track 4-6Anatomical and functional Neural circuits
- Track 4-7Neuropathological disorders
- Track 4-8Neurosurgery Diagnostic Tests
A Neuron communicates its electrical activity to other cells by releasing chemicals at the Junction of the two cells, that process is known as Neurochemical transmission. The chemical substances which transfer an electrical impulse from a nerve cell to its target cell are known as neurotransmitters.
- Track 5-1Dopamine
- Track 5-2Serotonin
- Track 5-3Neuropeptides
- Track 5-4Monoamines
- Track 5-5Human Synapses
- Track 5-6Chemical Neurotransmitters
- Track 5-7Neurotransmission receptors
- Track 5-8Advances in astrocyte-neuron interactions in health and disease
- Track 5-9Interneurons: coordinators of neuronal synchrony
- Track 5-10Drug interaction in various stages in neurotransmitters
Neuro-oncology defines the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. For example: glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumours etc. Most Commonly used treatments in neuro-oncology are Radiotherapy, Chemotherapy, Corticosteroids and Neurosurgical Interventions.
- Track 6-1Central Nervous System Cancers
- Track 6-2Neuropathology
- Track 6-3Neuroimaging and novel technologies
- Track 6-4Clinical problems in neurooncology
- Track 6-5Radiation Oncology
- Track 6-6Pediatric Neuro-oncology
- Track 6-7Metastatic tumors
- Track 6-8Neurobiology
- Track 6-9Brain and Spinal Cord Tumors
- Track 6-10Neurotoxicity and Neuroprotection
Cognitive neurology is a scientific study of neural mechanism underlying cognition. Cognitive Neurology is concerned with the diagnosis and treatment of diseases that affect memory and other ‘cognitive’ faculties (such as language, perception, planning-ability and social comportment). Cognitive neuroscience is at the intersection of psychology and neuroscience, but it also overlaps with physiological psychology, neuropsychology and cognitive psychology. This combines the theories of cognitive psychology & computational modelling with experimental data about the brain.
- Track 7-1Neurocognitive
- Track 7-2Cognition psychology
- Track 7-3Evolution and Social Cognition
- Track 7-4Cognitive development
- Track 7-5Methods of cognitive neurosciencce
- Track 7-6Neurobehavioral and Cognitive Disorders
- Track 7-7Cognitive Genomics & behavioural genetics
- Track 7-8Cognitive rehabilitation therapy
- Track 7-9Cognitive remediation therapy
The spinal cord refers as the main pathway for information connecting/transferring to the brain and peripheral nervous system. The spinal cord is also known as the large group of nerves which runs through the centre of the spinal cord and carries messages between the brain and the entire body. Spinal disorders may be seen in individuals irrespective of their age-Chiari malformation in infants to spinal stenosis in the elderly. The increase in population with spinal diseases has met with a leap in the advancements in diagnostic and treatment techniques. The commonly used tools in diagnosing spinal disorders are as follows: X rays, MRI, CT and DEA etc.
- Track 8-1Spinal Cord Injury
- Track 8-2Spinal Disorders Test
- Track 8-3Spine tumors
- Track 8-4Transverse Myelitis
- Track 8-5Syringomyelia
- Track 8-6Spina Bifida
- Track 8-7Spinal stroke
- Track 8-8Scoliosis Spine
- Track 8-9Sciatica
- Track 8-10Spinal Stenosis
- Track 8-11Levels of Injury
- Track 8-12Spinal Column Anatomy
- Track 8-13Therapeutic approaches for spinal disorders
Transduction may be defined as the method that converts a sensory signal to an electrical signal to be processed in a specialized area in the brain.
The brain has it specific processing regions that are dedicated to processing the information which has previously passed through the thalamus for both motor and sensory signals. Growth Factor and Cytokine receptors plays very important role in the activation of the signal transduction.
- Track 9-1Neurophysiology
- Track 9-2Cytokines
- Track 9-3Cell Signaling and Signal Transduction Pathways
- Track 9-4CNS Inflammation
Neurogenesis defines the process by which neurons are generated from neural stem cells and progenitor cells. Many different varieties of excitatory & inhibitory neurons are generated from different kinds of neural stem cells. The molecular and genetic factors influencing genesis of neuron notably include the Notch Signalling pathway, and many genes have been linked to Notch Signalling pathway regulation. It has been found to occur in two brain regions: the subventricular zone and the hippocampus.
- Track 10-1Neurogenesis
- Track 10-2Mechanisms of neurogenesis
- Track 10-3Neuronal Migration
- Track 10-4Neurons and Neuronal system
- Track 10-5Neural Development
- Track 10-6Adult neurogenesis
- Track 10-7Neuroplasticity
Neuro-pharmaceutics studies focuses on discovery of therapeutic targets, and then translating those discoveries into drug and therapy development. It is the largest potential growth sector of the pharmaceutical industry. However, this growth is blocked by the problem of the blood-brain barrier.
- Track 11-1Neuro Immune Pharmacology
- Track 11-2Neuroethics
- Track 11-3Avalilable therapeutics
- Track 11-4Neural circuits regulating appetite
- Track 11-5Clinical Pharmacists
- Track 11-6Surgical aggression and Anesthesia
- Track 11-7Physical Therapy
- Track 11-8Antipsychotic drugs/ Neuroleptics
- Track 11-9Psychopharmacology
- Track 11-10Clinical Neuropharmacology
- Track 11-11Molecular Neuropharmacology
- Track 11-12Future Aspects of Neuropharmacology
Clinical Aspects relating to or based on work done with real patients: of or relating to the medical treatment that is given to patients in hospitals, clinics, etc. It involves direct observation of the patient and based on or characterized by observable and diagnosable symptom. For example: Tumours of the Central Nervous System, Clinical Aspects of CNS Cysticercosis, Basic and Clinical Aspects of Malignant Melanoma etc.
- Track 12-1CNS tuberculosis
- Track 12-2Neurodegenerative Disorders
- Track 12-3Neuroimmunological Disorders
- Track 12-4Genetic testing for CNS disorders
- Track 12-5Remedies for CNS & Neurological Disorders
Neurology and Neuroscience is the special branch of medical Sciences that deals primarily with the disorders in the CNS. Neurophysiology defined as a union of both neurology and physiology and it studies the functioning of the nervous system.
- Track 13-1Case studies related to CNS disorders
- Track 13-2Case studies on Child Neurology
- Track 13-3Case studies on Neuroimmunology
- Track 13-4Case studies on Neurooncology
- Track 13-5Case reports on Brain Disorders
- Track 13-6Case studies on Cerebrovascular Cisorders
- Track 13-7Case studies and ethical issues
With an ever increasing average life expectancy, Neurological and CNS Disorders are becoming more prevalent in society. The economic and social costs of Neurological and CNS Disorders to society are huge. Many big pharmaceutical companies have moved away from CNS and Neurology research.
This meeting will give delegates an opportunity to gain additional knowledge and insights into the best practices in clinical trials, as well as addressing the challenges in CNS and Neurology research and by looking at the latest preclinical and clinical studies.
- Track 14-1 Clinical development in MS, PD and AD
- Track 14-2 Biomarkers implication in clinical trials
- Track 14-3 Current challenges in translational CNS research
- Track 14-4 Improvment of clinical trial development
- Track 14-5 Facilitating and establishing industry and academic partnering
- Track 14-6 Clinical trial safety and evaluation
- Track 14-7 New approaches for the design of clinical trials
The term Biomarker can be defined as a measurable indicator of some biological state or condition. A biomarker can also be known as a biological biomarker.
CNS 2016 conference focuses on the development of CNS biomarkers for drugs and diagnostics from Cerebrospinal fluid and Blood, as well as imaging approaches. Scientific data, updates and case studies in neurological and neurodegenerative diseases will be presented on disease areas such as Alzheimer's and Parkinson's.
- Track 15-1 Supporting CNS drug development using biomarkers
- Track 15-2 Cerebral CSF flow studies
- Track 15-3 Cerebrospinal fluid biomarkers
- Track 15-4 Neuroimaging enrichment biomarkers for CNS diseases
- Track 15-5 Biomarker Challenges in Rare Diseases
- Track 15-6 Technology case studies for CNS
The neuroscience perspective relates to the way that people act in terms of how they came to be. It deals with the scientific study of the nervous system and recognized as the branch of biology. On the other hand, neurology perspective deals with the branch of medicine dealing with the disorders of nervous system, diagnosis and treatment of all kind of diseases in the central nervous system and peripheral nervous system.
- Track 16-1Cognitive Neuroscience
- Track 16-2Clinical neurophysiology
- Track 16-3Computational Neuroscience
- Track 16-4Neuroimmunology
- Track 16-5Neuro Engineering
- Track 16-6Neurorehabilitation
- Track 16-7Neurological Nursing
The remarkable advances in animal models, genetics, biomarker development, and drug discovery have led to the development of novel neurotherapeutics. Innovative treatments include neurochemical and molecular targets, genes and epigenetic therapies, cognitive construct-based behavioral interventions, as well as neural circuitry-based therapies such as deep brain stimulation and magnetic stimulation.
- Track 17-1Anti-neurodegenerative drug discovery
- Track 17-2Nanoparticles as drug carriers
- Track 17-3Role of drug metabolism in drug development
- Track 17-4Enzyme kinetics
- Track 17-5Metabolism mediated drug-drug interactions
- Track 17-6Blood brain barrier (BBB)
- Track 17-7Centrally acting analgesics
- Track 17-8Neurotransmitters, neuromodulators, and neuroreceptors
- Track 17-9Neural stem cells and gene or cell therapy
- Track 17-10Ion channels, transporters and neurotransmitter receptors
- Track 17-11Neurological Drug Targets